Winnett V, Sirdaarta J, White A, Clarke F M, Cock I E
Environmental Futures Research Institute, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, QLD, 4111, Australia.
School of Natural Sciences, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, QLD, 4111, Australia.
Inflammopharmacology. 2017 Apr;25(2):223-235. doi: 10.1007/s10787-017-0328-1. Epub 2017 Feb 27.
A wide variety of herbal remedies are used in traditional Australian medicine to treat inflammatory disorders, including autoimmune inflammatory diseases. One hundred and six extracts from 40 native Australian plant species traditionally used for the treatment of inflammation and/or to inhibit bacterial growth were investigated for their ability to inhibit the growth of a microbial trigger for ankylosing spondylitis (K. pneumoniae). Eighty-six of the extracts (81.1%) inhibited the growth of K. pneumoniae. The D. leichardtii, Eucalyptus spp., K. flavescens, Leptospermum spp., M. quinquenervia, Petalostigma spp., P. angustifolium, S. spinescens, S. australe, S. forte and Tasmannia spp. extracts were effective K. pneumoniae growth inhibitors, with MIC values generally <1000 µg/mL. The T. lanceolata peppercorn extracts were the most potent growth inhibitors, with MIC values as low as 16 µg/mL. These extracts were examined by non-biased GC-MS headspace analysis and comparison with a compound database. A notable feature was the high relative abundance of the sesquiterpenoids polygodial, guaiol and caryophyllene oxide, and the monoterpenoids linalool, cineole and α-terpineol in the T. lanceolata peppercorn methanolic and aqueous extracts. The extracts with the most potent K. pneumoniae inhibitory activity (including the T. lanceolata peppercorn extracts) were nontoxic in the Artemia nauplii bioassay. The lack of toxicity and the growth inhibitory activity of these extracts against K. pneumoniae indicate their potential for both preventing the onset of ankylosing spondylitis and minimising its symptoms once the disease is established.
澳大利亚传统医学使用各种各样的草药疗法来治疗炎症性疾病,包括自身免疫性炎症性疾病。对40种澳大利亚本土传统用于治疗炎症和/或抑制细菌生长的植物物种的106种提取物进行了研究,以考察它们抑制强直性脊柱炎的一种微生物触发因素(肺炎克雷伯菌)生长的能力。其中86种提取物(81.1%)抑制了肺炎克雷伯菌的生长。莱氏桉、桉属植物、黄栌、细籽属植物、五脉金合欢、瓣蕊花属植物、狭叶胡椒、刺蒴麻、南方刺蒴麻、强壮刺蒴麻和塔斯马尼亚属植物的提取物是有效的肺炎克雷伯菌生长抑制剂,其最低抑菌浓度(MIC)值一般<1000微克/毫升。披针叶胡椒提取物是最有效的生长抑制剂,MIC值低至16微克/毫升。通过无偏差的气相色谱-质谱顶空分析并与化合物数据库进行比较对这些提取物进行了检测。一个显著特点是,披针叶胡椒甲醇提取物和水提取物中倍半萜类化合物多香木醛、愈创木醇和氧化石竹烯,以及单萜类化合物芳樟醇、桉叶素和α-松油醇的相对丰度较高。具有最强肺炎克雷伯菌抑制活性的提取物(包括披针叶胡椒提取物)在卤虫无节幼体生物测定中无毒。这些提取物缺乏毒性且对肺炎克雷伯菌具有生长抑制活性,表明它们在预防强直性脊柱炎发病以及在疾病发生后减轻其症状方面均具有潜力。